Spots Global Cancer Trial Database for Trial of Endostar Combined With CHOPT for T Cell Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Trial of Endostar Combined With CHOPT for T Cell Lymphoma
Official Title: Phase II Trial of Endostar Combined With CHOPT for T Cell Lymphoma
Study ID: NCT01430013
Conditions
Interventions
Study Description
Brief Summary: To evaluate the efficacy and safety of Endostar combined with CHOPT in the treatment of T cell lymphoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Contact Details
Name: Huaqing wang, MD
Affiliation: Tianjin Medical University Cancer Institue and Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
